We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
As drug pricing moves at the federal level have floundered, state officials have taken matters into their own hands. But Massachusetts is discovering there's a limit to drug-pricing innovation.